<- Go Home
BB Biotech AG
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
Market Cap
CHF 2.3B
Volume
89.9K
Cash and Equivalents
CHF 81.9M
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
CHF 201.4M
Profit Margin
100.00%
52 Week High
CHF 41.65
52 Week Low
CHF 24.35
Dividend
4.38%
Price / Book Value
0.98
Price / Earnings
13.59
Price / Tangible Book Value
0.98
Enterprise Value
CHF 2.2B
Enterprise Value / EBITDA
N/A
Operating Income
CHF 174.7M
Return on Equity
7.32%
Return on Assets
4.53
Cash and Short Term Investments
CHF 81.9M
Debt
N/A
Equity
CHF 2.3B
Revenue
CHF 201.4M
Unlevered FCF
-CHF 2.1B
Sector
Capital Markets
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium